The Central Nervous System, often abbreviated CNS, is the processing center of the body, which consists of the brain and the spinal cord. Basically, the CNS is responsible for functions like awareness, movement, thinking, speech, and even the five senses – sight, smell, touch, hearing, and taste. The mere thought of living with an impaired CNS or diseases like dementia, Alzheimer’s, Parkinson’s, or Rett syndrome can be frightening because of how disabling getting through life could become. The truth of the matter is that the longer a person lives, the higher their chance of experiencing a medical condition that impacts the CNS. Anavex Life Sciences claims to be working on understanding devastating CNS conditions in their first scientific educational video news release.
Anavex Life Sciences claims to be targeting CNS conditions by utilizing genomic biomarkers to develop therapeutics for people of all ages. As they further deepen their work and research on CNS, they have also discovered some interesting facts about certain diseases, and they are sharing this information in their first ever scientific video news release. This particular video touches on the etiology of Alzheimer’s disease and discusses new research that explains how women are more prone to develop dementia when compared to men.
Through their educational video news releases, the team at Anavex Life Sciences is hoping to broaden the understanding of the science behind their work in the biopharmaceutical industry, as they continue to pursue developing life improving treatments for CNS conditions.
Visit https://www.anavex.com/ to know more.
About Anavex Life Sciences
Anavex Life Sciences Corp. is a person-focused, biopharmaceutical company dedicated to therapeutic discovery and the development of targeted CNS treatments.